Xofigo

Added: May 25, 2017 8:37 am









VA250-17-N-0652

SPECIAL NOTICE

NOTICE OF INTENT TO SOLE SOURCE



Xofigo



The Department of Veterans Affairs, The Louis Stokes Cleveland Department of Veteran Affairs Medical Center, 10701 East Boulevard, Cleveland, Ohio 44106 intends to solicit and negotiate with only one source under the authority of FAR 6.302-1(a)(2), Only one responsible source and no other supplies or services will satisfy agency requirements. The VA intends to solicit and negotiate with Cardinal Health 414, Inc., 7710 First Place, Oakwood Village, OH 44146, for Xofigo.



Xofigo is used to treat prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to your bones with symptoms, but not to other parts of your body. Xofigo contains the radioactive material radium 223.



The Government believes that only one business can satisfy the agency requirements and intends to negotiate with only one source under the authority of FAR 6.302-1(a)(2), Only one responsible source and no other supplies or services will satisfy agency requirements. Other persons may identify their interest and capability to respond to this requirement by Monday, May 29, 2017 at 5PM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government.  A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available at this time.   All inquiries must be submitted by email to Rachelle Hamer at rachelle.hamer@va. Enter RFQ VA250-17-N-0652 Xofigo in the email subject line.